Amylin Pharmaceuticals - 2/15

Entry	Author	Date	Location
CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication	Luke Timmerman	04/18/11	San Diego
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug	Luke Timmerman	04/15/11	San Diego
Amylin Suspends Obesity Drug Development, Sapphire Energy Partners with Monsanto, 23andMe Gets Connected to UCSD’s Fowler, & More San Diego Life Sciences News	Bruce V. Bigelow	03/17/11	San Diego
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News	Erin Kutz	03/04/11	Boston
Amylin, Lilly, Alkermes Diabetes Drug Doesn’t Match Rival in Head-to-Head Study	Ryan McBride	03/03/11	Boston
Diagnostics Are Warming Up in Era of Fast, Cheap Sequencing, Says MDV’s Rowan Chapman	Luke Timmerman	02/07/11	San Francisco
San Diego’s Fight Against Diabesity: The Photo Gallery	Luke Timmerman	01/28/11	San Diego
Novartis Acquires Genoptix, Elcelyx Raises $6M, Pfenex Gets Subcontract to Work on Malaria Treatment, & More San Diego Life Sciences News	Bruce V. Bigelow	01/27/11	San Diego
See You Tonight at “San Diego’s Fight Against Diabesity”	Luke Timmerman	01/27/11	San Diego
Stealthy Elcelyx Therapeutics, Focused on Diabetes, Raises $6M	Bruce V. Bigelow	01/26/11	San Diego
Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug	Luke Timmerman	01/21/11	San Diego
San Diego’s Quest to Fight the “Diabesity” Epidemic, Coming Jan. 27	Luke Timmerman	01/13/11	San Diego
Illumina Launches Desktop Gene Sequencer, Avalon Raises $200M for Ninth Fund, Quidel Offering Raises Capital for New Strategy, & More San Diego Life Sciences News	Bruce V. Bigelow	01/13/11	San Diego
John Mendlein Tries His Hand as a ‘Parallel Entrepreneur,’ Santaris Continues RNA Therapeutics Work for Pfizer, & More San Diego Life Sciences News	Bruce V. Bigelow	01/06/11	San Diego
How Can San Diego Win the Fight Against Diabesity? Xconomy to Dig Deep on Jan. 27	Luke Timmerman	12/27/10	San Diego
Anaphore Snags $110M Deal With Mitsubishi Tanabe to Make Drugs for Immune Disorders	Luke Timmerman	12/13/10	San Diego
San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can Startups Still Thrive?	Luke Timmerman	12/03/10	San Diego
Intarcia Bets It Will Shake Up Diabetes Treatment With Implantable Device	Luke Timmerman	11/29/10	San Francisco
The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny?	Luke Timmerman	11/22/10	San Diego
Alkermes CEO Leans on Internal Pipeline as Bydureon Hangs Out in the Penalty Box	Ryan McBride	11/15/10	Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News	Erin Kutz	10/22/10	Boston
Amylin, Alkermes Shares Crash on Surprise FDA Smackdown	Luke Timmerman	10/20/10	San Diego
Amylin, Alkermes Once-Weekly Diabetes Drug Fails to Win FDA Approval	Luke Timmerman	10/19/10	San Diego
Amylin, Alkermes Eagerly Await FDA Verdict (Again) For Once-Weekly Diabetes Drug	Luke Timmerman	10/15/10	San Diego
Orexigen Nabs $1B Deal With Takeda to Market Obesity Drug, Shares Climb	Luke Timmerman	09/02/10	San Diego
Sanofi Buys TargeGen, Biogen Idec Hires CEO, Orexigen Obesity Drug Shows Promise Against Diabetes, & More San Diego Life Sciences News	Bruce V. Bigelow	07/01/10	San Diego
Orexigen Drug Shows Potential as “Two-Fer” Against Obesity and Diabetes	Luke Timmerman	06/25/10	San Diego
Amylin Cuts 60 Jobs	Luke Timmerman	06/24/10	San Diego
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News	Erin Kutz	05/07/10	Boston
Amylin, Alkermes Get New FDA Date	Luke Timmerman	05/06/10	National
Page 2 of 5	« previous page · next page »

Entry

Author

Date

Location

CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication

Luke Timmerman

04/18/11

San Diego

Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug

Luke Timmerman

04/15/11

San Diego